feed,title,long_url,short_url
MedRxiv,Burden of SARS-CoV-2 and protection from symptomatic second infection in children,https://medrxiv.org/cgi/content/short/2022.01.03.22268684v1?rss=1,https://j.mp/3JG4CGN
MedRxiv,Seroresponse to third doses of SARS-CoV-2 vaccine among patients receiving maintenance dialysis,https://medrxiv.org/cgi/content/short/2022.01.03.21268549v1?rss=1,https://j.mp/3eT3YY3
MedRxiv,"The French domestic ""sanitary pass"" did not solve Covid-19 vaccination inequities in France",https://medrxiv.org/cgi/content/short/2022.01.03.22268676v1?rss=1,https://j.mp/3G10xdM
MedRxiv,Full title: COVID-19 disease progression according to initial symptoms. A telemedicine cohort study.,https://medrxiv.org/cgi/content/short/2022.01.03.22268669v1?rss=1,https://j.mp/3EZlzZ9
MedRxiv,Test to release from isolation after testing positive for SARS-CoV-2,https://medrxiv.org/cgi/content/short/2022.01.04.21268372v1?rss=1,https://j.mp/3GeqZkx
MedRxiv,Bayesian Estimation of real-time Epidemic Growth Rates using Gaussian Processes: local dynamics of SARS-CoV-2 in England,https://medrxiv.org/cgi/content/short/2022.01.01.21268131v1?rss=1,https://j.mp/3eW5Qzw
MedRxiv,Preliminary modeling estimates of the relative transmissibility and immune escape of the Omicron SARS-CoV-2 variant of concern in South Africa,https://medrxiv.org/cgi/content/short/2022.01.04.22268721v1?rss=1,https://j.mp/3eZ2mMk
MedRxiv,Daily Lactobacillus Probiotic versus Placebo in COVID-19-Exposed Household Contacts (PROTECT-EHC): A Randomized Clinical Trial,https://medrxiv.org/cgi/content/short/2022.01.04.21268275v1?rss=1,https://j.mp/3mXLn1m
MedRxiv,Safety and immunogenicity of anti-SARS CoV-2 conjugate vaccine SOBERANA 02 in a two-dose or three-dose heterologous scheme in adults: Phase IIb Clinical Trial,https://medrxiv.org/cgi/content/short/2022.01.01.21268271v1?rss=1,https://j.mp/3G10xKO
